Director/PDMR Shareholding
IXICO plc announced that its Non-Executive Chair, Mark Warne, a Person Discharging Managerial Responsibilities (PDMR), purchased 50,006 ordinary shares at 7.975 pence per share on July 15, 2026. Following this acquisition, Mr. Warne now holds a total of 247,341 ordinary shares, representing 0.11% of the company's issued share capital. This transaction is an indication of insider confidence in the company's performance and future prospects.
Select text to share a quote on X · sign in to keep highlights & notes in your IXI notes
15 July 2026: IXICO plc (AIM: IXI), IXICO, a global leader in neuroscience imaging and biomarker analytics, using its AI-driven platform to help advance drug development and diagnostics in neurological disorders, announces that it has been notified that on 15 July 2026, Mark Warne, Non-Executive Chair and a PDMR of the Company, purchased 50,006 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") at a price of 7.975 pence per Ordinary Share.
As a result, Mark Warne is now interested in a total of 247,341 Ordinary Shares, representing 0.11% of the Company's issued share capital.
| a) | Name | Mark Warne |
| 2 | Reason for the notification | |
| a) | Position/status | Non-Executive Chair |
| b) | Initial notification /Amendment | Initial |
| a) | Name | IXICO plc |
| b) | LEI | 2138005M1F59O6HWSA97 |
| a) | Description of the financial instrument, type of instrument | Ordinary shares in IXICO plc |
| Identification code | ISIN: GB00BFXR4C20 | |
| b) | Nature of the transaction | Acquisition of Ordinary shares |
| c) | Price(s) and volume(s) | |
| Price(s) | Volume(s) | |
| 0.07975 | 50,006 | |
| d) | Aggregated information | |
| - Aggregated volume | N/A one transaction | |
| - Price | ||
| e) | Date of the transaction | 15/07/2026 |
| f) | Place of the transaction | London |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.